tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tandem Diabetes price target raised to $11 from $10.35 at Citi
PremiumThe FlyTandem Diabetes price target raised to $11 from $10.35 at Citi
1M ago
Tandem Diabetes Care: Strategic Growth Potential and Market Expansion Drive Buy Rating
Premium
Ratings
Tandem Diabetes Care: Strategic Growth Potential and Market Expansion Drive Buy Rating
1M ago
Tandem Diabetes upgraded to Neutral from Sell at Citi
Premium
The Fly
Tandem Diabetes upgraded to Neutral from Sell at Citi
1M ago
Positive Outlook for Tandem Diabetes Care: Buy Rating Reaffirmed Amid Growth Catalysts and Strategic Opportunities
PremiumRatingsPositive Outlook for Tandem Diabetes Care: Buy Rating Reaffirmed Amid Growth Catalysts and Strategic Opportunities
2M ago
Tandem Diabetes Care’s Earnings Call Highlights Growth and Challenges
Premium
Company Announcements
Tandem Diabetes Care’s Earnings Call Highlights Growth and Challenges
2M ago
Tandem Diabetes Care Gains FDA Clearance for SteadiSet
Premium
Company Announcements
Tandem Diabetes Care Gains FDA Clearance for SteadiSet
2M ago
Tandem Diabetes price target lowered to $13 from $20 at Wells Fargo
PremiumThe FlyTandem Diabetes price target lowered to $13 from $20 at Wells Fargo
2M ago
Tandem Diabetes downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Tandem Diabetes downgraded to Neutral from Overweight at Piper Sandler
2M ago
Tandem Diabetes Care Reports Record Q2 2025 Sales
Premium
Company Announcements
Tandem Diabetes Care Reports Record Q2 2025 Sales
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100